Cargando…
MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
Introduction: Prader-Willi syndrome (PWS) is a neurodevelopmental disorder caused by the absence of paternal genes on chromosome 15. It affects both sexes equally. It has an incidence of ~1 in 15,000 births and a worldwide prevalence of ~400,000. PWS is the most common obesity-linked syndrome. Hyper...
Autores principales: | Mottalib, Adham, Hafida, Samar, Mitri, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550974/ http://dx.doi.org/10.1210/js.2019-MON-095 |
Ejemplares similares
-
MON-093 Myokine Levels after Resistance Exercise in Young Adults with Prader-Willi Syndrome (PWS)
por: Hirsch, Harry, et al.
Publicado: (2019) -
MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Milano, Stephane, et al.
Publicado: (2019) -
SAT-095 The Impact of CPAP on Intensive Calorie Restriction Weight Loss
por: Mao, Yuanjie, et al.
Publicado: (2019) -
SUN-604 U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims
por: McCandless, Shawn E, et al.
Publicado: (2020) -
SUN-595 Comparative Comorbidity Burden Among Patients with Prader-Willi Syndrome: A Population-Level Cohort Study
por: Stafford, Diane E J, et al.
Publicado: (2020)